Bradley Canino
Stock Analyst at Stifel
(1.16)
# 3,578
Out of 4,876 analysts
89
Total ratings
30%
Success rate
-11.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bradley Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | Maintains: Buy | $16 → $15 | $2.36 | +535.59% | 5 | Mar 7, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Hold | $3 → $1.5 | $0.41 | +269.64% | 8 | Mar 7, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $27 → $23 | $3.30 | +596.97% | 5 | Feb 27, 2025 | |
| ARVN Arvinas | Maintains: Buy | $63 → $51 | $7.54 | +576.39% | 6 | Feb 12, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $70 → $115 | $23.18 | +396.12% | 2 | Dec 3, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $40 → $41 | $9.03 | +354.29% | 5 | Oct 14, 2024 | |
| KURA Kura Oncology | Downgrades: Hold | $26 → $19 | $5.67 | +235.10% | 6 | Oct 14, 2024 | |
| CELC Celcuity | Maintains: Buy | $39 → $42 | $12.50 | +236.00% | 4 | Oct 7, 2024 | |
| SMMT Summit Therapeutics | Maintains: Buy | $25 → $40 | $20.64 | +93.85% | 4 | Sep 25, 2024 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $79.67 | +69.45% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $10.32 | +93.80% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.13 | +788.89% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $10 | $1.18 | +747.46% | 17 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $99 | $52.95 | +86.97% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $1.40 | +900.00% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $7.80 | +412.82% | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $130 | $128.11 | +1.48% | 5 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $44.12 | +24.66% | 4 | Feb 23, 2024 |
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $2.36
Upside: +535.59%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3 → $1.5
Current: $0.41
Upside: +269.64%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27 → $23
Current: $3.30
Upside: +596.97%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63 → $51
Current: $7.54
Upside: +576.39%
Janux Therapeutics
Dec 3, 2024
Maintains: Buy
Price Target: $70 → $115
Current: $23.18
Upside: +396.12%
Syndax Pharmaceuticals
Oct 14, 2024
Maintains: Buy
Price Target: $40 → $41
Current: $9.03
Upside: +354.29%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $5.67
Upside: +235.10%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39 → $42
Current: $12.50
Upside: +236.00%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25 → $40
Current: $20.64
Upside: +93.85%
Nuvalent
Sep 16, 2024
Maintains: Buy
Price Target: $115 → $135
Current: $79.67
Upside: +69.45%
Sep 6, 2024
Initiates: Buy
Price Target: $20
Current: $10.32
Upside: +93.80%
Aug 8, 2024
Initiates: Buy
Price Target: $10
Current: $1.13
Upside: +788.89%
Jun 18, 2024
Maintains: Buy
Price Target: $32 → $10
Current: $1.18
Upside: +747.46%
Jun 17, 2024
Maintains: Buy
Price Target: $90 → $99
Current: $52.95
Upside: +86.97%
May 9, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $1.40
Upside: +900.00%
May 1, 2024
Initiates: Buy
Price Target: $40
Current: $7.80
Upside: +412.82%
Apr 26, 2024
Maintains: Buy
Price Target: $120 → $130
Current: $128.11
Upside: +1.48%
Feb 23, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $44.12
Upside: +24.66%